# Alberto Martini

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alberto-martini/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,579 |
| Field | Autoimmune and Inflammatory Disorders Research |
| h-index | 111 |
| i10-index | 447 |
| Last Known Institution | Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna |
| OpenAlex ID | https://openalex.org/A5027612338 |
| ORCID iD | https://orcid.org/0000-0001-7642-1459 |
| Works | 1,048 |

## Researcher papers

- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating-2/)
- [ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study](https://scholariq.org/papers/ada2-deficiency-dada2-as-an-unrecognised-cause-of-early-onset-polyarteritis/)
- [EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation](https://scholariq.org/papers/eular-printo-pres-criteria-for-henoch-schonlein-purpura-childhood-polyarteritis/)
- [Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-intravenous-belimumab-in-children-with-systemic-lupus/)
- [Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension](https://scholariq.org/papers/long-term-efficacy-and-safety-of-infliximab-plus-methotrexate-for-the-treatment/)

## Researcher topics

- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna](https://scholariq.org/institutions/agenzia-regionale-prevenzione-e-ambiente-della-regione-emilia-romagna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.